ImmuCell Corp

NASDAQ:ICCCUnited States

ImmuCell Corporation is an animal health company. The Company is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. It manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. It expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The Company is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.

Contact Information

Headquarters

56 Evergreen DrPORTLAND, ME, United States 04103-1066

Phone

207-878-2770

Fax

302-655-5049

Executives

Chairman of the Board

David Tomsche

President, Chief Executive Officer, Treasurer, Secretary, Director

Michael Brigham

Chief Scientific Officer, Vice President

Joseph Crabb

Vice President - Sales and Marketing, Director

Bobbi Brockmann

Vice President - Manufacturing Operations

Elizabeth Williams